Cardiff Park Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $82.9K | Buy |
+1,000
| New | +$82.9K | 0.01% | 293 |
|
|
2024
Q4 | – | Sell |
-501
| Closed | -$49.5K | – | 351 |
|
|
2024
Q3 | $49.5K | Sell |
501
-2,506
| -83% | -$247K | ﹤0.01% | 293 |
|
|
2024
Q2 | $279K | Buy |
3,007
+4
| +0.1% | +$371 | 0.03% | 201 |
|
|
2024
Q1 | $285K | Buy |
3,003
+500
| +20% | +$47.4K | 0.03% | 206 |
|
|
2023
Q4 | $224K | Hold |
2,503
| – | – | 0.02% | 217 |
|
|
2023
Q3 | $183K | Hold |
2,503
| – | – | 0.02% | 218 |
|
|
2023
Q2 | $208K | Hold |
2,503
| – | – | 0.03% | 225 |
|
|
2023
Q1 | $191K | Hold |
2,503
| – | – | 0.03% | 223 |
|
|
2022
Q4 | $208K | Hold |
2,503
| – | – | 0.03% | 225 |
|
|
2022
Q3 | $199K | Hold |
2,503
| – | – | 0.03% | 226 |
|
|
2022
Q2 | $186K | Hold |
2,503
| – | – | 0.03% | 231 |
|
|
2022
Q1 | $225K | Hold |
2,503
| – | – | 0.03% | 217 |
|
|
2021
Q4 | $280K | Buy |
+2,503
| New | +$280K | 0.04% | 196 |
|